1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical trial simulation to optimize trial design for fludarabine dosing strategies in allogeneic hematopoietic cell transplantation
    Journal Article

    Langenhorst, J. B.; Dorlo, T. P. C.; van Kesteren, C.; van Maarseveen, E. M.; Nierkens, S.; de Witte, M. A.; Boelens, J. J.; Huitema, A. D. R.
    CPT: Pharmacometrics and Systems Pharmacology (2020)

    Fulltext@MSK | Save
  • Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): Post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
    Journal Article

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • HSD3B1 genotype and clinical outcomes in metastatic castration-sensitive prostate cancer
    Journal Article

    Hearn, J. W. D.; Sweeney, C. J.; Almassi, N.; Reichard, C. A.; Reddy, C. A.; Li, H.; Hobbs, B.; Jarrard, D. F.; Chen, Y. H.; Dreicer, R.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma
    Journal Article

    O'Reilly, E. M.; Barone, D.; Mahalingam, D.; Bekaii-Saab, T.; Shao, S. H.; Wolf, J.; Rosano, M.; Krause, S.; Richards, D. A.; Yu, K. H.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
    Journal Article

    Schroeder, M. A.; Jean Khoury, H.; Jagasia, M.; Ali, H.; Schiller, G. J.; Staser, K.; Choi, J.; Gehrs, L.; Arbushites, M. C.; Yan, Y.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Do children and adolescents with completely resected alveolar rhabdomyosarcoma require adjuvant radiation? A report from the Children's Oncology Group
    Journal Article

    Aye, J. M.; Chi, Y. Y.; Tian, J.; Rudzinski, E. R.; Binitie, O. T.; Dasgupta, R.; Wolden, S. L.; Hawkins, D. S.; Gupta, A. A.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • ‘Don’t know’ responding and estimates of perceived risk: Failing to provide a ‘don’t know’ response systematically biases laypeople’s perceived risk estimates
    Journal Article

    Kiviniemi, M. T.; Ellis, E. M.; Orom, H.; Waters, E. A.; Hay, J. L.
    Health, Risk and Society (2020)

    Fulltext@MSK | Save
  • Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: A randomized clinical trial
    Journal Article

    Bombard, Y.; Clausen, M.; Shickh, S.; Mighton, C.; Casalino, S.; Kim, T. H. M.; Muir, S. M.; Carlsson, L.; Baxter, N.; Scheer, A.; more...
    Genetics in Medicine (2020)

    Fulltext@MSK | Save
  • Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: The ANNOUNCE randomized clinical trial
    Journal Article

    Tap, W. D.; Wagner, A. J.; Schöffski, P.; Martin-Broto, J.; Krarup-Hansen, A.; Ganjoo, K. N.; Yen, C. C.; Abdul Razak, A. R.; Spira, A.; Kawai, A.; more...
    JAMA - Journal of the American Medical Association (2020)

    Fulltext@MSK | Save
  • Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)
    Journal Article

    Ryan, C. J.; Dutta, S.; Kelly, W. K.; Russell, C.; Small, E. J.; Morris, M. J.; Taplin, M. E.; Halabi, S.; From The Alliance for Clinical Trials in Oncology Genitourinary Committee
    Prostate Cancer and Prostatic Diseases (2020)

    Fulltext@MSK | Save